![](/img/cover-not-exists.png)
Denleukin diftitox (Ontak) for the treatment of advanced steroid refractory graft-versus-host disease (SR-GVHD): A single institution experience
J.S. Bubalo, R.T. Maziarz, N. Subbiah, P.T. Curtin, A. Simic, B.M. Hayes-Lattin, S.E. Schubach, C.E. Jacoby, J.F. LeisVolume:
11
Year:
2005
Language:
english
DOI:
10.1016/j.bbmt.2004.12.148
File:
PDF, 51 KB
english, 2005